Daito Pharmaceutical Co Ltd
TSE:4577

Watchlist Manager
Daito Pharmaceutical Co Ltd Logo
Daito Pharmaceutical Co Ltd
TSE:4577
Watchlist
Price: 2 124 JPY -1.12% Market Closed
Market Cap: 32.5B JPY
Have any thoughts about
Daito Pharmaceutical Co Ltd?
Write Note

Daito Pharmaceutical Co Ltd
Interest Income Expense

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
TTM
|

Daito Pharmaceutical Co Ltd
Interest Income Expense Peer Comparison

Comparables:
4502
4568
4578
4519
4503

Competitive Interest Income Expense Analysis
Latest Figures & CAGR of Competitors

Company Interest Income Expense CAGR 3Y CAGR 5Y CAGR 10Y
Daito Pharmaceutical Co Ltd
TSE:4577
Interest Income Expense
ÂĄ860m
CAGR 3-Years
31%
CAGR 5-Years
64%
CAGR 10-Years
N/A
Takeda Pharmaceutical Co Ltd
TSE:4502
Interest Income Expense
-ÂĄ157.5B
CAGR 3-Years
-6%
CAGR 5-Years
-2%
CAGR 10-Years
N/A
Daiichi Sankyo Co Ltd
TSE:4568
Interest Income Expense
ÂĄ34.8B
CAGR 3-Years
100%
CAGR 5-Years
69%
CAGR 10-Years
N/A
Otsuka Holdings Co Ltd
TSE:4578
Interest Income Expense
ÂĄ40B
CAGR 3-Years
43%
CAGR 5-Years
30%
CAGR 10-Years
15%
Chugai Pharmaceutical Co Ltd
TSE:4519
Interest Income Expense
ÂĄ39m
CAGR 3-Years
-54%
CAGR 5-Years
-37%
CAGR 10-Years
N/A
Astellas Pharma Inc
TSE:4503
Interest Income Expense
-ÂĄ1.9B
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
-2%

See Also

What is Daito Pharmaceutical Co Ltd's Interest Income Expense?
Interest Income Expense
860m JPY

Based on the financial report for Aug 31, 2024, Daito Pharmaceutical Co Ltd's Interest Income Expense amounts to 860m JPY.

What is Daito Pharmaceutical Co Ltd's Interest Income Expense growth rate?
Interest Income Expense CAGR 5Y
64%

The average annual Interest Income Expense growth rates for Daito Pharmaceutical Co Ltd have been 31% over the past three years , 64% over the past five years .

Back to Top